THE KDM4-IN-4 DIARIES

lumacaftor/ivacaftor will reduce the level or impact of abemaciclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of abemaciclib with solid CYP3A4 inducers reduces plasma focus of abemaciclib and its metabolites.DailyMed will deliver notification of updates and additions to Drug Lab